<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has filed an initial disclosure on BSE as required for entities identified as a 'Large Corporate' under SEBI norms. The actual details of the disclosure (such as the company's classification details, outstanding borrowings, or incremental borrowing plans) could not be retrieved as the linked BSE page returned a broken/error response. Large Corporate disclosure is a mandatory annual filing under SEBI's framework that applies to listed companies meeting certain market capitalisation and borrowing thresholds. Without the underlying data table, specific numbers and figures from this filing cannot be confirmed.
This is a routine regulatory compliance filing and is unlikely to have a material impact on the stock price or shareholders. Investors may want to check the actual disclosure details later on BSE/NSE to verify the company's Large Corporate status and any related incremental borrowing requirements.